Table 1 Clinicopathological relevance of miR-1307 upregulation in ovarian carcinoma
From: The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer
Parameters | Case no. | miR-1307 level | p value |
|---|---|---|---|
Age | 0.8011 | ||
Postmenopause | 25 | 2.137 ± 1.1457 | |
Before menopause | 15 | 2.540 ± 1.1282 | |
Differentiation status | 0.6080 | ||
High or medium | 18 | 2.917 ± 1.0120 | |
Low | 22 | 2.138 ± 1.297 | |
Clinical stage | 0.4985 | ||
Stage I | 3 | 1.404 ± 0.8790 | |
Stage II | 8 | 3.880 ± 1.4341 | |
Stage III | 29 | 3.945 ± 1.3631 | |
Lymph node metastasis | 0.3257 | ||
Yes | 15 | 2.497 ± 1.3521 | |
No | 25 | 4.347 ± 2.0142 |